OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reprogramming Energy Metabolism with Synthesized PDK Inhibitors Based on Dichloroacetate Derivatives and Targeted Delivery Systems for Enhanced Cancer Therapy
Wenyan She, Tingting Liu, Haimei Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14683-14699
Closed Access | Times Cited: 4
Wenyan She, Tingting Liu, Haimei Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14683-14699
Closed Access | Times Cited: 4
Showing 4 citing articles:
Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer
Wenyan She, Haimei Li, Zichen Wang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 204-220
Closed Access | Times Cited: 7
Wenyan She, Haimei Li, Zichen Wang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 204-220
Closed Access | Times Cited: 7
Discovery of Atp Competitive Pdhk1/2 Dual Inhibitors
Guangtian Zou, Hong‐Tao Xu, Dong Ding, et al.
(2025)
Closed Access
Guangtian Zou, Hong‐Tao Xu, Dong Ding, et al.
(2025)
Closed Access
Recent advances in pyruvate dehydrogenase kinase inhibitors: Structures, inhibitory mechanisms and biological activities
Yiyang Li, Zhizhong Xie, Xiaoyong Lei, et al.
Bioorganic Chemistry (2024), pp. 107160-107160
Closed Access | Times Cited: 3
Yiyang Li, Zhizhong Xie, Xiaoyong Lei, et al.
Bioorganic Chemistry (2024), pp. 107160-107160
Closed Access | Times Cited: 3
Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts
Tomas Koltai, Larry Fliegel
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 744-744
Open Access | Times Cited: 3
Tomas Koltai, Larry Fliegel
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 744-744
Open Access | Times Cited: 3
Targeting the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation
Lin‐Ling Gan, Ying Yang, Zizhen Liang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116008-116008
Closed Access | Times Cited: 7
Lin‐Ling Gan, Ying Yang, Zizhen Liang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116008-116008
Closed Access | Times Cited: 7
